Jan Endrikat

2.6k total citations
94 papers, 1.9k citations indexed

About

Jan Endrikat is a scholar working on Public Health, Environmental and Occupational Health, Radiology, Nuclear Medicine and Imaging and Materials Chemistry. According to data from OpenAlex, Jan Endrikat has authored 94 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Public Health, Environmental and Occupational Health, 25 papers in Radiology, Nuclear Medicine and Imaging and 20 papers in Materials Chemistry. Recurrent topics in Jan Endrikat's work include Reproductive Health and Contraception (26 papers), Lanthanide and Transition Metal Complexes (20 papers) and Advanced MRI Techniques and Applications (19 papers). Jan Endrikat is often cited by papers focused on Reproductive Health and Contraception (26 papers), Lanthanide and Transition Metal Complexes (20 papers) and Advanced MRI Techniques and Applications (19 papers). Jan Endrikat collaborates with scholars based in Germany, United States and Switzerland. Jan Endrikat's co-authors include Christoph Gerlinger, B. Düsterberg, W. Schmidt, Jens Wessel, Hubertus Pietsch, Thomas Frenzel, Ulrich Büscher, Martin R. Prince, Ulrich Müller and R. Heithecker and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Roentgenology and Journal of Magnetic Resonance Imaging.

In The Last Decade

Jan Endrikat

88 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Endrikat Germany	26	684	435	404	399	189	94	1.9k
Miranda M Fidler-Benaoudia Canada	24	611 0.9×	186 0.4×	56 0.1×	142 0.4×	109 0.6×	43	3.4k
Rebecca Kirch United States	10	563 0.8×	194 0.4×	49 0.1×	64 0.2×	91 0.5×	17	3.3k
Steve Scoppa United States	11	449 0.7×	223 0.5×	41 0.1×	81 0.2×	101 0.5×	17	3.7k
Catherine C. Lerro United States	8	241 0.4×	192 0.4×	38 0.1×	83 0.2×	85 0.4×	18	2.9k
Matthew Burnell United Kingdom	25	327 0.5×	159 0.4×	36 0.1×	778 1.9×	176 0.9×	66	3.3k
Lynda Wyld United Kingdom	31	412 0.6×	405 0.9×	168 0.4×	43 0.1×	54 0.3×	149	3.8k
Simon Van Belle Belgium	32	686 1.0×	282 0.6×	20 0.0×	312 0.8×	47 0.2×	135	4.3k
Rachel Cannady United States	18	775 1.1×	237 0.5×	41 0.1×	83 0.2×	161 0.9×	26	4.8k
Dexter L. Cooper United States	13	284 0.4×	174 0.4×	38 0.1×	65 0.2×	82 0.4×	25	2.8k
Anne Blaes United States	29	469 0.7×	360 0.8×	26 0.1×	74 0.2×	122 0.6×	194	3.6k

Countries citing papers authored by Jan Endrikat

Since Specialization

Citations

This map shows the geographic impact of Jan Endrikat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Endrikat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Endrikat more than expected).

Fields of papers citing papers by Jan Endrikat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Endrikat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Endrikat. The network helps show where Jan Endrikat may publish in the future.

Co-authorship network of co-authors of Jan Endrikat

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Endrikat. A scholar is included among the top collaborators of Jan Endrikat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Endrikat. Jan Endrikat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Endrikat, Jan, et al.. (2025). Clinical Safety of Gadoxetate Disodium. Investigative Radiology. 61(4). 272–278.

Endrikat, Jan, et al.. (2025). Rationales for Non-standard GBCA Dosing—Low?—High?—When? and Why?. Investigative Radiology.

Frenzel, Thomas, et al.. (2025). Recent Developments and Future Perspectives in Magnetic Resonance Imaging and Computed Tomography Contrast Media. Investigative Radiology. 61(3). 214–223. 4 indexed citations

Endrikat, Jan, et al.. (2024). Awareness of Breast Cancer Risk Factors in Women with vs. Without High Breast Density. Patient Preference and Adherence. Volume 18. 1577–1588.

Endrikat, Jan, et al.. (2024). Does the risk of hypersensitivity reactions to iopromide differ by sex, race, or across regions/countries? An analysis of 152 233 patients from 4 observational studies and the company’s pharmacovigilance database. British Journal of Radiology. 97(1164). 2004–2014. 1 indexed citations

Endrikat, Jan, et al.. (2024). Clinical Safety of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations. Investigative Radiology. 59(9). 605–613. 11 indexed citations

Schmidt, G, Christina Schneider, Christoph Gerlinger, et al.. (2019). Impact of body mass index, smoking habit, alcohol consumption, physical activity and parity on disease course of women with triple-negative breast cancer. Archives of Gynecology and Obstetrics. 301(2). 603–609. 6 indexed citations

Michaely, Henrik J., Manuela Aschauer, Hannes Deutschmann, et al.. (2016). Gadobutrol in Renally Impaired Patients. Investigative Radiology. 52(1). 55–60. 41 indexed citations

Schmidt, G, Christoph Gerlinger, Elmar Stickeler, et al.. (2016). Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer. Journal of Cancer Research and Clinical Oncology. 142(6). 1369–1376. 12 indexed citations

10.

Gerlinger, Christoph, Luke Bamber, Friedhelm Leverkus, et al.. (2016). Comparing The EQ-5D-5L Value Sets Across Diferent Countries – Impact on Inpertretation of Clinical Study Results. Value in Health. 19(7). A389–A389. 4 indexed citations

11.

Endrikat, Jan, Carsten Schwenke, & Martin R. Prince. (2015). Gadobutrol for contrast-enhanced magnetic resonance imaging in elderly patients: review of the safety profile from clinical trial, post-marketing surveillance, and pharmacovigilance data. Clinical Radiology. 70(7). 743–751. 18 indexed citations

12.

Gerlinger, Christoph, James Trussell, Uwe Mellinger, et al.. (2014). Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population. Contraception. 90(2). 142–146. 14 indexed citations

13.

Schumacher, Ulrike, Jens Schumacher, Uwe Mellinger, et al.. (2012). Estimation of menstrual blood loss volume based on menstrual diary and laboratory data. BMC Women s Health. 12(1). 24–24. 19 indexed citations

14.

Endrikat, Jan, Heather Shapiro, Eeva Lukkari‐Lax, et al.. (2009). A Canadian, Multicentre Study Comparing the Efficacy of a Levonorgestrel-releasing Intrauterine System to an Oral Contraceptive in Women With Idiopathic Menorrhagia. Journal of Obstetrics and Gynaecology Canada. 31(4). 340–347. 55 indexed citations

15.

Endrikat, Jan, et al.. (2007). A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1 mg estradiol valerate/2 mg dienogest on hot flushes in postmenopausal women. Maturitas. 58(2). 201–207. 14 indexed citations

16.

Endrikat, Jan, et al.. (2007). A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 μg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight. The European Journal of Contraception & Reproductive Health Care. 12(3). 220–228. 12 indexed citations

17.

Endrikat, Jan, et al.. (2003). Projektive Identifizierung und Schwangerschaftsverdrängung - Überlegungen zu Ursachen und Hintergründen der auch ärztlicherseits nicht erkannten Schwangerschaft. Zeitschrift für Geburtshilfe und Neonatologie. 207(2). 48–53. 10 indexed citations

18.

Wessel, Jens, Jan Endrikat, & Ulrich Büscher. (2003). Elevated risk for neonatal outcome following denial of pregnancy: results of a one-year prospective study compared with control groups. Journal of Perinatal Medicine. 31(1). 29–35. 31 indexed citations

19.

Endrikat, Jan, et al.. (2001). Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel. Contraception. 64(3). 201–207. 27 indexed citations

20.

Winkler, Ulrich, Alexander Schindler, Jan Endrikat, & B. Düsterberg. (1996). A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiol. Contraception. 53(2). 75–84. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact